Delivery Order SPE2DB22D2103-SPE2DB24FR8PG

Award Date 11/27/23
Potential Completion Date 11/28/23
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,017.77, is for the supply of BUTALB-ACETAMIN-CAFF 50-325-40 500S, a prescription medication product. The delivery order is a firm fixed price contract with a completion date of July 25, 2024. AmerisourceBergen, the prime contractor, does not have a small business set-aside for this award. The contract is part of a larger...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $1,474.20 with a firm fixed price and an ultimate completion date of February 21, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567331087 - BUTALB-ACETAMIN-CAFF 50-325-40 100S, a pharmaceutical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,176.38 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BUTALB-ACETAMIN-CAFF 50-325-40 100S medical products. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award, valued at $4,033.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product. This is a delivery order contract with a firm fixed-price pricing type. The award has an ultimate completion date of August 22, 2024. No set-aside designation is mentioned. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,132.58 firm fixed-price delivery order is for the supply of the drug "BUTALB-ACETAMIN-CAF-COD 50-300 100S" and has a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency Troop Support Medical awarded a $25,050 delivery order to Amerisourcebergen Drug Corporation for 4562299532 BUTALB-ACETAMIN-CAFF 50-325-40 100S. The firm fixed price order is for pharmaceutical products to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer or location. The delivery order was issued on September 25, 2023 under an existing indefinite-delivery/indefinite-quantity contract vehicle and has a period of...
This federal contract award, valued at $1,234.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4565244187 ! ACETAMINOPHEN-COD 3 TABLET 100S, with a period of performance through July 25, 2024. The contract is not designated as a set-aside and was awarded competitively. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $49,043.14, is for the procurement of various pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, vials, and other medical commodities. The contract is a Firm Fixed Price (FFP) delivery order, with a period of performance through May 6, 2024. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,056.24, is for the delivery of various pharmaceutical products and medical supplies to support military healthcare programs. The contract is a firm fixed-price arrangement and has an ultimate completion date of January 21, 2025. This delivery order is part of a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.28, is for the delivery of a variety of pharmaceutical products and medical supplies to support military healthcare programs. The contract has a firm fixed price pricing type and a completion date of February 24, 2025. This delivery order is part of a larger...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR8PG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,096.11, is for the delivery of BUTALB-ACETAMIN-CAF-COD 50-300 100S, a pharmaceutical product, with a period of performance through November 28, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 9:55 AM